Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Medpace Holdings, Inc.
Medpace Holdings, Inc. News
Medpace Holdings, Inc. Quantitative Score
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Medpace Holdings, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Medpace Holdings, Inc. Financials
Table Compare
Compare MEDP metrics with: | |||
|---|---|---|---|
Earnings & Growth | MEDP | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | MEDP | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | MEDP | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | MEDP | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Medpace Holdings, Inc. Income
Medpace Holdings, Inc. Balance Sheet
Medpace Holdings, Inc. Cash Flow
Medpace Holdings, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Strong Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Medpace Holdings, Inc. Executives
| Name | Role |
|---|---|
| Dr. August James Troendle M.D. | Chairman & Chief Executive Officer |
| Ms. Susan E. Burwig BSN, MA | Executive Vice President of Operations |
| Mr. Jesse J. Geiger BBA, CPA | President |
| Mr. Stephen P. Ewald J.D. | Chief Compliance Officer, General Counsel & Corporate Secretary |
| Mr. Kevin M. Brady | Chief Financial Officer & Treasurer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Dr. August James Troendle M.D. | Chairman & Chief Executive Officer | 1956 | 1.53M | |
| Ms. Susan E. Burwig BSN, MA | Executive Vice President of Operations | Female | 1963 | 1.06M |
| Mr. Jesse J. Geiger BBA, CPA | President | Male | 1974 | 939.07K |
| Mr. Stephen P. Ewald J.D. | Chief Compliance Officer, General Counsel & Corporate Secretary | Male | 1969 | 871.95K |
| Mr. Kevin M. Brady | Chief Financial Officer & Treasurer | Male | 1975 | 656.75K |
Medpace Holdings, Inc. Insider Trades
| Date | 30 Jun |
| Name | McCarthy Cornelius P. III |
| Role | Director |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 50 |
| Date | 30 Jun |
| Name | McCarthy Cornelius P. III |
| Role | Director |
| Transaction | Disposed |
| Type | M-Exempt |
| Shares | 50 |
| Date | 30 Jun |
| Name | Kraft Robert O. |
| Role | Director |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 57 |
| Date | 30 Jun |
| Name | Kraft Robert O. |
| Role | Director |
| Transaction | Disposed |
| Type | M-Exempt |
| Shares | 57 |
| Date | 30 Jun |
| Name | Carley Brian T |
| Role | Director |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 62 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 30 Jun | McCarthy Cornelius P. III | Director | Acquired | M-Exempt | 50 |
| 30 Jun | McCarthy Cornelius P. III | Director | Disposed | M-Exempt | 50 |
| 30 Jun | Kraft Robert O. | Director | Acquired | M-Exempt | 57 |
| 30 Jun | Kraft Robert O. | Director | Disposed | M-Exempt | 57 |
| 30 Jun | Carley Brian T | Director | Acquired | M-Exempt | 62 |